article thumbnail

Legislation To Produce And Research Cannabis Introduced

NORML

As the result of a lawsuit, DEA Administrative Law Judge Mary Ellen Bittner in 2007 ruled that expanding the pool of federally licensed providers would be “in the public interest.” The agency ultimately rejected her decision. Click here to send a message to your federal lawmaker and urge them to support the measure. .

article thumbnail

AIMS v. Garland: A Disappointment for Psilocybin Advocates, but Progressive Policy May Still be on the Horizon

Cannabis Law Report

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). The RTT Act.

DEA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. On May 3, 2021, our study of MDMA-assisted therapy for PTSD achieved successful results for patients with severe, chronic PTSD. Lyle Craker, Ph.D., Source: [link].

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Review: During an open-label trial of pure CBD with Lennox-Gastaut and Dravet patients, 79% of all patients reported side effects.

article thumbnail

CBD, THC, AND CANCER

Weedistry

Guzman administered pure THC via a catheter into the tumors of nine hospitalized patients with glioblastoma, who had failed to respond to standard brain-cancer therapies. A team of Spanish scientists led by Manuel Guzman conducted the first clinical trial assessing the antitumoral action of THC on human beings.

THC 40
article thumbnail

Here?s where the 2020 Presidential Candidates Stand on Cannabis

The Joint Blog

A patient or a leisure seeker should be mindful of the cannabis laws, otherwise your trip to paradise might end up in a nightmare. Remember that he made a similar comment in May 2017 when signing that fiscal year’s appropriations bill into law, and yet no raids against state-legal medical marijuana patients or providers followed.

article thumbnail

Meadowlands: Update from Local Regulators with the Cannabis Czars of Los Angeles, San Francisco…

Meadow

Back in 2007, it said we don’t want anymore cannabis businesses and despite a general prohibition, we still had more cannabis businesses than any other location. Certain communities have experienced those impacts very differently so patients have experienced impacts differently. It’s every square inch of it.